ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Hohneker John
ArriVent BioPharma | 3: Initial statement of beneficial ownership of securities-Director Hohneker John
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine
ArriVent BioPharma | 3: Initial statement of beneficial ownership of securities-Director Peterson Kristine
ArriVent BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi Shi(6.4%),LAV Fund VI, L.P. (“LAVVI”)(6.2%), etc.
ArriVent BioPharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(9.1%),OrbiMed Capital GP VIII LLC(4.5%), etc.
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-10% Owner HILLHOUSE INVESTMENT MANAGEMENT, LTD.
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director GORDON CARL L
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Jallal Bahija
ArriVent BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Nolet Chris
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner HILLHOUSE INVESTMENT MANAGEMENT, LTD.
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Director ORBIMED ADVISORS LLC
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Yao Zhengbin
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Director Nolet Chris
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Lutzker Stuart
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer LaChapelle Robin
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Kung Winston
ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Kastenmayer James Paul
No Data